BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//PlainTrial//Saved Trials Calendar//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-WR-CALNAME:PlainTrial saved trials
X-WR-CALDESC:Estimated completion dates for the clinical trials you saved o
 n PlainTrial.
BEGIN:VEVENT
UID:plaintrial-NCT07192237-completion@plaintrial.com
DTSTAMP:20260928T063011Z
DTSTART;VALUE=DATE:20321012
SUMMARY:Phase 2 Study to Assess the Safety and Efficacy of Subcutaneous Bli
 natumomab in Patients With Measurable Residual Disease Positive B-cell Acu
 te Lymphoblastic Leukemia — estimated completion date
DESCRIPTION:Not yet recruiting. Saved on your PlainTrial shortlist. Full tr
 ial record: https://plaintrial.com/trial/NCT07192237
URL:https://plaintrial.com/trial/NCT07192237
END:VEVENT
END:VCALENDAR